Viatris (VTRS) Receivables - Other (2019 - 2026)
Viatris (VTRS) posted quarterly Receivables - Other of $499.0 million for Q1 2026, down 7.73% year-over-year from $540.8 million in Q1 2025, and up 9.98% quarter-over-quarter from $453.7 million in Q4 2025.
Viatris (VTRS) Receivables - Other (2019 - 2026) Analysis & Trends
Viatris' Receivables - Other history runs 8 years deep, the most recent figure standing at $499.0 million for Q1 2026.
- In Q1 2026, Receivables - Other fell 7.73% year-over-year to $499.0 million; the TTM figure through Mar 2026 stood at $499.0 million (down 7.73% YoY), while the FY2025 annual figure was $453.7 million, down 16.9% from the prior year.
- Receivables - Other for Q1 2026 stood at $499.0 million, up from $453.7 million in the prior quarter.
- The five-year high for Receivables - Other was $882.5 million in Q2 2024, with the low at $453.7 million in Q4 2025.
- The 5-year median for Receivables - Other is $537.0 million (2022), against an average of $591.6 million.
- The sharpest annual moves came in 2024 and 2025: Receivables - Other surged 82.49% in 2024, then sank 47.43% in 2025.
- Viatris' Receivables - Other stood at $570.7 million in 2022, then surged by 53.6% to $876.6 million in 2023, then slumped by 37.71% to $546.0 million in 2024, then slipped by 16.9% to $453.7 million in 2025, then increased by 9.98% to $499.0 million in 2026.
- Business Quant data shows VTRS's Receivables - Other at $499.0 million in Q1 2026, $453.7 million in Q4 2025, and $459.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 545.10 Mn |
| Jun 30, 2026 | 545.10 Mn |
| Mar 31, 2026 | 499.00 Mn |
| Mar 31, 2026 | 499.00 Mn |
| Dec 31, 2025 | 453.70 Mn |
| Dec 31, 2025 | 453.70 Mn |
| Sep 30, 2025 | 459.50 Mn |
| Sep 30, 2025 | 459.50 Mn |
| Jun 30, 2025 | 463.90 Mn |
| Jun 30, 2025 | 463.90 Mn |
| Mar 31, 2025 | 540.80 Mn |
| Mar 31, 2025 | 540.80 Mn |
| Dec 31, 2024 | 546.00 Mn |
| Dec 31, 2024 | 546.00 Mn |
| Sep 30, 2024 | 861.00 Mn |
| Sep 30, 2024 | 861.00 Mn |
| Jun 30, 2024 | 882.50 Mn |
| Jun 30, 2024 | 882.50 Mn |
| Mar 31, 2024 | 842.00 Mn |
| Mar 31, 2024 | 842.00 Mn |